SCHEMBL8410205

SCHEMBL8410205

CC(=O)Oc1c(NC(=O)C(C)C)ccc(Br)c1C(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM4 O15151 2/20 0.39
TP53 P04637 2/20 0.39
KMT2A Q03164 1/20 0.38
THRA P10827 1/20 0.37
THRB P10828 1/20 0.37
ALDH1A1 P00352 6/20 0.37
MLYCD O95822 1/20 0.36
GAA P10253 1/20 0.35
CETP P11597 1/20 0.35
KDM4E B2RXH2 4/20 0.34
LMNA P02545 3/20 0.34
MAPK1 P28482 2/20 0.34
TSHR P16473 2/20 0.34
ATM Q13315 1/20 0.34
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
HTT P42858 2/20 0.33
CES2 O00748 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8410669 0.87 KDM4E (0.42) MDM4TP53KMT2ATHRATHRB
SCHEMBL8410321 0.81 ALDH1A1 (0.51) MDM4TP53KMT2AALDH1A1LMNA
SCHEMBL8407481 0.80 MDM4 (0.44) MDM4TP53KMT2ATHRATHRB
SCHEMBL8409108 0.79 MDM4 (0.43) MDM4TP53KMT2ATHRATHRB
SCHEMBL13199440 0.74 RXFP1 (0.45) ALDH1A1KDM4ELMNATSHRATM
SCHEMBL7752718 0.70 RXFP1 (0.53) KMT2AALDH1A1ATMCYP1A2CYP3A4
SCHEMBL8409951 0.68 ALDH1A1 (0.53) MDM4TP53KMT2AALDH1A1LMNA
SCHEMBL8409970 0.67 MDM4 (0.45) MDM4TP53KMT2AALDH1A1MLYCD
SCHEMBL5660190 0.67 THRB (0.61) KMT2ATHRATHRBALDH1A1GAA
SCHEMBL8409003 0.67 AR (0.55) MDM4TP53KMT2AALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5994362-A ADMINISTERING FINASTERIDE AND CASODEX MERCK & CO., INC. (US) 1999-11-30 US disclosed
EP-0514056-A2 Use of estrogens or antiandrogens for reversal of male sexual phenotype in poultry MERCK & CO. INC. (US) 1992-11-19 EP disclosed
WO-1992016233-A1 PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF PROSTATIC CANCER CONTAINING A 5 ALPHA REDUCTASE INHIBITOR AND AN ANTIANDROGEN MERCK & CO., INC. (US) 1992-10-01 WO disclosed